Novavax Covid-19 vaccine

  • Coronavirus World

    European regulators approve Novavax Covid-19 vaccine

    European regulators have approved the Novavax Covid-19 vaccine after months of delays. The protein-based vaccine takes a similar approach to that of vaccines long deployed against meningitis, hepatitis, and other illnesses. It provides European countries with another weapon in the fight against Covid-19, but according to a Bloomberg report, its efficacy against the newly-emerged Omicron variant is not yet known.…

  • Indonesia

    Indonesia approves Novavax Covid-19 vaccine for emergency use

    The Indonesian government has approved the Novavax Covid-19 vaccine for emergency use, the first country in the world to do so. The Bangkok Post reports that the manufacturer and its partner, Serum Institute of India, has confirmed the approval. The vaccine will be sold under the brand name Covovax. The manufacturers have applied for emergency use authorisation in several countries,…

  • Coronavirus Vaccines

    Thammasat University seeks to import alternative Covid-19 vaccines

    The hospital director of Thammasat University says the institution is seeking a partner to help with importing alternative Covid-19 vaccines. Dr Pharuhat Tor-Udom says the process would be similar to how Chulabhorn Royal Academy procures vaccines through the Thai Red Cross. CRA sources the Sinopharm vaccine through the society, which is authorised to deal directly with vaccine manufacturers. According to…

  • Coronavirus (Covid-19)

    Doctor urges Pfizer, Moderna vaccine to fight B.1.351 variant

    Reacting to the news that the B.1.351 variant of Covid-19 (commonly nicknamed the South African variant) has now been found in Thailand, a senior doctor at the Siriraj Centre of Research Excellence Management has called upon the government to obtain Pfizer, Moderna, and Johnson & Johnson vaccine as quickly as possible. In a Facebook post yesterday, the doctor suggested that…

  • World

    Novavax says vaccine 100% effective at preventing severe illness, hospitalisation

    The US firm Novavax says trials on its Covid-19 vaccine have shown it to be 100% effective at preventing serious illness, hospitalisation or death from the virus. However, the efficacy rate fell sharply against mild to moderate cases of the South African variant. The Bangkok Post reports that one phase 3 trial took place in the UK and included 15,000…